【正文】
ilability and bioequivalence studies for orally administered drug products: general considerations. , 2022 相關(guān)指導(dǎo)原則(續(xù)) ? European Medicines Agency. Guideline on the investigation of bioequivalence. docs/en_GB/document_library/Scientific_guideline/2010/01/, 2022 ? The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit, Committee for Proprietary Medicinal Products. Note for guidance on modified release oral and transdermal dosage forms: Section II (Pharmacokiic and clinical evaluation). , 1999